Private Equity Buyout Boom Peaks in April: 156 Deals Worth 123 Billion Show Mega-Fund Dominance

Eighty-one billion dollars in private equity acquisitions closed in a single week.

April 10th through April 11th saw 46 PE-backed deals announced—Hologic going private for $18.3 billion, Sealed Air acquired for $10.3 billion, and CVC closing in on a €10.9 billion Recordati takeover. By mid-month, the deal flow had not slowed. PE firms closed 156 acquisitions across April alone, representing $123 billion in disclosed transaction values—a surge that reflects how aggressively mega-funds are deploying capital after months of steady LP inflows.

This is not a recovery. It's a recalibration. And for deal-hungry operators, it signals something important: the era of defensive PE is ending.

The April Acceleration: Why The Mega-Deals Arrived in Waves

The clustering matters. April's deal surge did not arrive as a steady flow—it arrived as discrete waves, each coinciding with announcements of closed mega-funds or LP capital commitments. The Hologic and Sealed Air completions both landed on April 10th and 11th. This is not coincidence. PE firms with newly closed funds signal to the market they are ready to deploy.

KKR closed a $23 billion North America Fund in early April. Blackstone, Apollo, and Carlyle all closed mega-funds in March. The result: a burst of activity as GPs transition from fundraising to deployment. Hologic—a medical device firm that had explored strategic options for months—became a takeover target the moment PE firms had fresh capital to deploy. Sealed Air followed days later.

What makes April distinct from Q1 is the composition. Earlier in the quarter, PE activity was suppressed by uncertainty around financing costs and credit markets. By April, that uncertainty had cleared. Credit spreads stabilized, LP appetite remained strong, and mega-funds with fresh capital had limited time to deploy before facing pressure from their LPs.

The scale is significant: 156 deals in a single month suggests an annualized PE acquisition pace of 1,872 transactions. That would mark the highest annual PE acquisition volume in over a decade, exceeding even the 2021 peak when dry powder reached historic highs.

Mega-Deals Rule: But The Real Story Is Mid-Market Momentum

Of the 26 deals with publicly disclosed values, mega-deals ($1 billion or larger) accounted for 11 transactions. That concentration—42% of all disclosed deals being over $1 billion—masks a deeper shift in PE strategy.

For years, PE firms have complained about mid-market deal scarcity. The largest firms (Apollo, Blackstone, KKR, Carlyle) moved upmarket, chasing billion-dollar-plus takeouts. Smaller PE firms, starved of mid-market exit opportunities, retreated into add-on acquisition strategies or lower-middle-market consolidation plays.

But April's pattern suggests this is changing. The 130 deals with undisclosed values likely skew smaller—$100 million to $500 million range based on source patterns. Regional PE firms, family offices, and smaller mega-funds are finding targets they can size appropriately. The Hologic and Sealed Air headline-grabbers obscure 100+ smaller takes-private and add-on acquisitions where mid-market PE is active.

This has consequences for sellers. Mid-market entrepreneurs who held out for strategic bids are now seeing PE appetite re-emerge. Business services, industrial software, and healthcare services are all seeing renewed PE interest. The Q1 M&A slowdown has flipped.

Technology Remains Prime Real Estate—But Healthcare and Industrial Are Hot

Software continues to dominate PE acquisition targets, representing roughly 20% of April's deal volume. This reflects a simple fact: software and SaaS businesses trade at more stable multiples than hardware or industrial businesses, making them predictable sources of value creation for PE. HCSS combined with Nemetschek Build & Construct, ClassPass merged with Mindbody and EGYM in a $7.5 billion deal, and dozens of smaller software acquisitions landed throughout the month.

But the real momentum is in healthcare. Hologic's $18.3 billion take-private was driven by a simple thesis: medical device companies with stable cash flows and recurring revenue streams are attractive to PE, especially when public market multiples contract. Apellis, acquired by Biogen for $5.6 billion, reflects the same pattern—a specialty pharma business with a clear exit path through a larger acquirer.

Industrial manufacturing is seeing renewed PE attention as well. Energy infrastructure, logistics software, and construction services all saw multiple PE acquisitions in April. These sectors offer what PE firms want: recurring revenue, pricing power, and clear consolidation opportunities.

Consumer and retail remain dormant. Food brands and direct-to-consumer businesses saw minimal PE acquisition activity, reflecting persistent consumer spending uncertainty. Infrastructure and renewables remain politically complicated despite ESG LP demand, keeping deal flow lower than headline coverage suggests.

What This Means: Deployment Risk Is Real, But Opportunity Is Broader

156 PE acquisitions in April is not normal. It reflects a moment when mega-fund deployments align, credit markets cooperate, and target companies have no choice but to engage with offers they cannot ignore. Hologic shareholders faced a takeout they could not refuse. Sealed Air saw fair value through a PE-backed acquisition and agreed to a take-private.

But this pace is not sustainable indefinitely. Mega-fund deployment has a finite horizon. Once KKR, Blackstone, and Apollo have deployed 30-40% of their funds, the urgency will ease. By summer, expect deal flow to normalize to 80-100 acquisitions monthly—still elevated, but not at April's fever pitch.

The real risk is multiple compression. If PE firms are acquiring at 7-8x EBITDA today, but public market multiples fall to 5x by year-end, they will face instant paper losses on their acquisitions. This is why mid-market deals matter. They offer PE firms more flexibility to adjust value creation plans mid-hold. Mega-deals leave less room for error.

For entrepreneurs and their advisors, April is a window. PE appetite is high, deployment is urgent, and competition is real. By Q3, that window may narrow. Deal flow tends to mean-revert, and April's 156 acquisitions will look exceptional by comparison.

The mega-deals grabbed headlines. The real story is the 100+ smaller acquisitions flowing through the market. That is where mid-market PE is finding its footing again.